Effects of atorvastatin on expression of VCAM-1 in atherosclerotic rabbits
Jiayin Zhang
Abstract
Jiayin Zhang
Abstract
Objective To investigate the expression of VCAM-1 in atherosclerotic rabbits and effects of ator-vastatin in anti-atherosclerosis. Methods Twenty four rabbits were randomly divided into control,cholesterol diet, and atorvastatin group,which were fed for 16 weeks. Serum TC,TG,LDL were measured in 0 and 16 weeks in the three groups. After 16 weeks,the aortas were harvested for pathologic morphology observation,immunohis-tochemistry analysis of VCAM-1 positive percentage and the measurement of VCAM-1 mRNA using reverse tran-scription-polymerase chain reaction(RT-PCR) were performed. Results Atorvastatin greatly reduced TC and LDL (P0. 01). Atherosclerosis was formed in cholesterol diet and atorvastatin group,the expressions of VCAM-1 and the measurement of VCAM-1 mRNA in cholesterol diet and atorvastatin group were higher than control(P 0. 01),but pathologic changes,intima thickness and intima/medium thickness ratio(I/M) in atorvastatin group reduced than cholesterol diet group(P0. 01) ,the expressions of VCAM-1 and the measurement of VCAM-1 mRNA were lower than cholesterol diet group(P0. 01). Conclusions VCAM-1 can be excessively expressed in atherosclerosis. Atorvastatin not only reduces cholesterole but also inhibits excessive expression of VCAM-1 and has the effect of anti-atherosclerosis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the expression of VCAM-1 in atherosclerotic rabbits and effects of ator-vastatin in anti-atherosclerosis. Methods Twenty four rabbits were randomly divided into control,cholesterol diet, and atorvastatin group,which were fed for 16 weeks. Serum TC,TG,LDL were measured in 0 and 16 weeks in the three groups. After 16 weeks,the aortas were harvested for pathologic morphology observation,immunohis-tochemistry analysis of VCAM-1 positive percentage and the measurement of VCAM-1 mRNA using reverse tran-scription-polymerase chain reaction(RT-PCR) were performed. Results Atorvastatin greatly reduced TC and LDL (P0. 01). Atherosclerosis was formed in cholesterol diet and atorvastatin group,the expressions of VCAM-1 and the measurement of VCAM-1 mRNA in cholesterol diet and atorvastatin group were higher than control(P 0. 01),but pathologic changes,intima thickness and intima/medium thickness ratio(I/M) in atorvastatin group reduced than cholesterol diet group(P0. 01) ,the expressions of VCAM-1 and the measurement of VCAM-1 mRNA were lower than cholesterol diet group(P0. 01). Conclusions VCAM-1 can be excessively expressed in atherosclerosis. Atorvastatin not only reduces cholesterole but also inhibits excessive expression of VCAM-1 and has the effect of anti-atherosclerosis.
Key concepts: Atorvastatin, VCAM-1, Cholesterol, Internal medicine, Endocrinology, Hyperlipidemia, Medicine, Biology